ResearcherShandong UniversityActive in the last 2 years
Chengli Li
Matched on ORCID iD 0000-0002-1820-4525; OpenAlex author ID A5047442653. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 20
2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 1 paper · 2022: none · 2023: none · 2024: 1 paper
Papers 3
- Guidelines for permanent iodine-125 seed interstitial brachytherapy for pancreatic cancer (2023 edition): The Chinese expert consensus workshop report. Co-author DOI 10.4103/jcrt.jcrt_2368_23↗
- Chinese expert consensus of image-guided irreversible electroporation for pancreatic cancer. Co-author DOI 10.4103/jcrt.jcrt_1663_20↗
- MRI-guided celiac plexus neurolysis for pancreatic cancer pain: Efficacy and safety. Last author DOI 10.1002/jmri.25246↗
Closest collaborators
The 20 strongest of 20 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Maoquan Li · 2 shared papers, 2021–2024 · strength 0.23
- Lizhi Niu · 2 shared papers, 2021–2024 · strength 0.23
- Zhongmin Wang · 1 shared paper, 2024 · strength 0.15
- Hongxin Niu · 1 shared paper, 2024 · strength 0.15
- Yuliang Li · 1 shared paper, 2024 · strength 0.15
- Baodong Gai · 1 shared paper, 2024 · strength 0.15
- Bin Liu · 1 shared paper, 2024 · strength 0.15
- Hong Zhao · 1 shared paper, 2024 · strength 0.15
- Fujun Zhang · 1 shared paper, 2024 · strength 0.15
- Yingtian Wei · 1 shared paper, 2021 · strength 0.08
- Tianan Jiang · 1 shared paper, 2021 · strength 0.08
- Yinying Lu · 1 shared paper, 2021 · strength 0.08
- Liwei Wang · 1 shared paper, 2021 · strength 0.08
- Ming Kuang · 1 shared paper, 2021 · strength 0.08
- Junhui Sun · 1 shared paper, 2021 · strength 0.08
- Haipeng Yu · 1 shared paper, 2021 · strength 0.08
- Kai‐Wen Huang · 1 shared paper, 2021 · strength 0.08
- Yingxun Zhang · 1 shared paper, 2021 · strength 0.08
- Xiaoyi Ding · 1 shared paper, 2021 · strength 0.08
- Shangang Liu · 1 shared paper, 2016 · strength 0.07
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.